![](/img/cover-not-exists.png)
PCN105 COST SAVINGS ASSOCIATED WITH BEVACIZUMAB-BASED THERAPY IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) IN GERMANY
E Schmidt, HG Bischoff, DF Heigener, S Stanisic, S WalzerVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)72000-9
File:
PDF, 70 KB
english, 2010